NO302522B1 - 4-pyrimidinyl- og pyridinylderivater av indolyl-3-yl-alkylpiperazin og farmasöytisk preparat som inneholder en slik forbindelse - Google Patents

4-pyrimidinyl- og pyridinylderivater av indolyl-3-yl-alkylpiperazin og farmasöytisk preparat som inneholder en slik forbindelse Download PDF

Info

Publication number
NO302522B1
NO302522B1 NO924764A NO924764A NO302522B1 NO 302522 B1 NO302522 B1 NO 302522B1 NO 924764 A NO924764 A NO 924764A NO 924764 A NO924764 A NO 924764A NO 302522 B1 NO302522 B1 NO 302522B1
Authority
NO
Norway
Prior art keywords
methoxy
indol
pyrimidinyl
mmol
propyl
Prior art date
Application number
NO924764A
Other languages
English (en)
Norwegian (no)
Other versions
NO924764D0 (no
NO924764L (no
Inventor
David W Smith
Frank D Yocca
Yoseph P Yevich
Ronald J Mattson
Andrew Williams
Edward H Ruediger
Keith Dean Combrink
Bradley Clyde Pearce
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO924764D0 publication Critical patent/NO924764D0/no
Publication of NO924764L publication Critical patent/NO924764L/no
Publication of NO302522B1 publication Critical patent/NO302522B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
NO924764A 1991-12-19 1992-12-10 4-pyrimidinyl- og pyridinylderivater av indolyl-3-yl-alkylpiperazin og farmasöytisk preparat som inneholder en slik forbindelse NO302522B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US81066191A 1991-12-19 1991-12-19
US95959292A 1992-10-13 1992-10-13

Publications (3)

Publication Number Publication Date
NO924764D0 NO924764D0 (no) 1992-12-10
NO924764L NO924764L (no) 1993-06-21
NO302522B1 true NO302522B1 (no) 1998-03-16

Family

ID=27123378

Family Applications (1)

Application Number Title Priority Date Filing Date
NO924764A NO302522B1 (no) 1991-12-19 1992-12-10 4-pyrimidinyl- og pyridinylderivater av indolyl-3-yl-alkylpiperazin og farmasöytisk preparat som inneholder en slik forbindelse

Country Status (15)

Country Link
US (1) US5434154A (fr)
EP (1) EP0548813A1 (fr)
JP (1) JPH05262762A (fr)
CN (1) CN1085556A (fr)
AU (1) AU661527B2 (fr)
CA (1) CA2084531A1 (fr)
CZ (1) CZ359292A3 (fr)
FI (1) FI925737A7 (fr)
IL (1) IL104024A (fr)
MX (1) MX9207114A (fr)
NO (1) NO302522B1 (fr)
NZ (1) NZ245439A (fr)
PH (1) PH30988A (fr)
RU (1) RU2114111C1 (fr)
TW (1) TW221420B (fr)

Families Citing this family (46)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521188A (en) * 1993-09-16 1996-05-28 Bristol-Myers Squibb Company Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
CA2130078A1 (fr) * 1993-09-16 1995-03-17 Jonas A. Gylys Derives cyclobutenediones de l'indolylakylpyridinyle et des pyrimidinylpiperazines ayant des proprietes antimigraineuses
US5468768A (en) * 1994-01-06 1995-11-21 Bristol-Myers Squibb Company Antimigraine derivatives of indolylcycloalkanylamines
GB9410031D0 (en) * 1994-05-19 1994-07-06 Merck Sharp & Dohme Therapeutic agents
US5552402A (en) * 1994-05-19 1996-09-03 Merck, Sharp & Dohme Ltd. Five-membered heteroaromatic compounds as 5-HT receptor agonists
EP0759918A1 (fr) * 1994-05-19 1997-03-05 MERCK SHARP & DOHME LTD. Derives piperazine, piperidine et tetrahydropyridine d'indol-3-ylalkyle utilises comme agonistes de 5-ht1d-alpha
US5567824A (en) * 1994-05-24 1996-10-22 Merck & Co., Inc. Palladium catalyzed ring closure of triazolyltryptamine
ES2079323B1 (es) * 1994-06-21 1996-10-16 Vita Invest Sa Derivados de indol utiles para el tratamiento de la migraña, composicion y uso correspondientes.
GB9415575D0 (en) * 1994-08-02 1994-09-21 Merck Sharp & Dohme Therapeutic agents
US5550239A (en) * 1994-11-08 1996-08-27 Bristol-Myers Squibb Company Process for large-scale production of indolyl alkyl pyrimidinyl piperazine compounds
GB9423682D0 (en) * 1994-11-23 1995-01-11 Merck Sharp & Dohme Therapeutic agents
WO1997011695A1 (fr) * 1995-09-28 1997-04-03 Merck Sharp & Dohme Limited Derives d'indolylpropyl-piperazine a substitution utilises comme agonistes de 5-ht¿1d alpha?
GB9501865D0 (en) * 1995-01-31 1995-03-22 Merck Sharp & Dohme Therapeutic agents
US5618816A (en) * 1995-03-02 1997-04-08 Bristol-Myers Squibb Company Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
US5889010A (en) * 1995-05-18 1999-03-30 Pfizer Inc. Benzimidazole derivatives having dopaminergic activity
AU707750B2 (en) * 1995-08-07 1999-07-22 Merck Sharp & Dohme Limited Substituted 1-indolylpropyl-4-phenethylpiperazine derivatives
JPH09124643A (ja) * 1995-08-14 1997-05-13 Bristol Myers Squibb Co 抗うつ作用を有する１−アリールアルキル−４−（アルコキシピリジニル）−又は４−（アルコキシピリミジニル）ピペラジン誘導体
GB9519563D0 (en) * 1995-09-26 1995-11-29 Merck Sharp & Dohme Therapeutic agents
US5998415A (en) * 1995-11-02 1999-12-07 Merck Sharp & Dohme Ltd. Bicyclic heteroaryl-alkylene-(homo)piperazinones and thione analogues thereof, their preparation, and their use of as selective agonists of 5-HT1 -like receptors
GB9523250D0 (en) * 1995-11-14 1996-01-17 Merck Sharp & Dohme Therapeutic agents
GB9609374D0 (en) * 1996-05-03 1996-07-10 Merck Sharp & Dohme Therapeutic agents
US5808064A (en) * 1996-08-13 1998-09-15 Merck & Co., Inc. Palladium catalyzed indolization
US5811551A (en) * 1996-08-13 1998-09-22 Merck & Co., Inc. Palladium catalyzed indolization
US5877329A (en) * 1996-08-13 1999-03-02 Merck & Co., Inc. Palladium catalyzed indolization
US5891885A (en) * 1996-10-09 1999-04-06 Algos Pharmaceutical Corporation Method for treating migraine
GB9714383D0 (en) * 1997-07-08 1997-09-10 Pfizer Ltd Improved process
DE19756036A1 (de) * 1997-12-17 1999-06-24 Merck Patent Gmbh Amid- und Harnstoffderivate
ATE374192T1 (de) * 2000-11-29 2007-10-15 Lilly Co Eli 1-(2-m-methansulfonamidophenylethyl)-4-(m- trifluoromethylphenyl)piperazine und ihre akzeptablen pharmazeutischen salze und solvate und ihre verwendung zur behandlung von inkontinenz
DE10102944A1 (de) * 2001-01-23 2002-07-25 Merck Patent Gmbh Verfahren zur Herstellung von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon und dessen Salzen
US20030017175A1 (en) * 2001-07-05 2003-01-23 R.T. Alamo Ventures I, Inc. Sublingual administration of dihydroergotamine for the treatment of migraine
US6685951B2 (en) 2001-07-05 2004-02-03 R. T. Alamo Ventures I, Inc. Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
US20030198669A1 (en) * 2001-07-05 2003-10-23 R.T. Alamo Ventures I, Llc Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
WO2003068741A1 (fr) * 2002-02-13 2003-08-21 Meiji Dairies Corporation Derives d'indole substitues avec des alcools a longue chaine et medicaments contenant ceux-ci
DE102004047517A1 (de) * 2004-09-28 2006-03-30 Merck Patent Gmbh Neuartige Kristallform von (3-Cyan-1H-indol-7-yl)-[4-(4-fluorphenethyl)-piperazin-1-yl]-methanon, Hydrochlorid
WO2006129190A1 (fr) * 2005-06-03 2006-12-07 Glenmark Pharmaceuticals Limited Procede de preparation de l'almotriptan
RU2461556C2 (ru) * 2006-12-30 2012-09-20 Эбботт Гмбх Унд Ко. Кг Замещенные производные оксидола и их применение в качестве лигандов рецептора вазопрессина
WO2008097664A1 (fr) 2007-02-11 2008-08-14 Map Pharmaceuticals, Inc. Procédé d'administration thérapeutique de dhe pour procurer un soulagement rapide de la migraine tout en minimisant le profil des effets secondaires
EP2036888A1 (fr) * 2007-09-17 2009-03-18 Laboratorios del Dr. Esteve S.A. Sulfonamides à substitution naphtyl
WO2013016223A2 (fr) 2011-07-22 2013-01-31 The University Of Chicago Traitements de la migraine et de troubles apparentés
AU2013361337A1 (en) 2012-12-21 2015-07-09 Map Pharmaceuticals, Inc. 8'-Hydroxy-Dihydroergotamine compounds and compositions
CN104163813B (zh) * 2013-05-16 2017-02-01 广东东阳光药业有限公司 取代的吲哚化合物及其使用方法和用途
WO2015014256A1 (fr) 2013-07-29 2015-02-05 Sunshine Lake Pharma Co., Ltd. Composés hétéroaryle substitués et procédés d'utilisation
CN104725363B (zh) * 2013-12-20 2019-03-01 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途
EP3083589B1 (fr) * 2013-12-20 2019-12-18 Sunshine Lake Pharma Co., Ltd. Composés pipéraziniques substitués et leurs procédés d'utilisation
US10316025B2 (en) 2015-06-03 2019-06-11 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use and use thereof
CN111386272B (zh) * 2017-10-27 2023-01-06 费森尤斯卡比肿瘤学有限公司 一种改进的瑞博西尼及其盐的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (fr) * 1959-09-25 1900-01-01
GB1189064A (en) 1967-05-01 1970-04-22 Sterling Drug Inc Indole Derivatives
IT1170387B (it) 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB2162522B (en) 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative
US4954502A (en) * 1988-06-10 1990-09-04 Bristol-Myers Squibb Company 1-indolyalkyl-4-(substituted-pyridinyl)piperazines
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
GB8830312D0 (en) 1988-12-28 1989-02-22 Lundbeck & Co As H Heterocyclic compounds
JP2871811B2 (ja) 1990-02-28 1999-03-17 サントリー株式会社 縮合７員環系化合物
US5077293A (en) * 1990-06-29 1991-12-31 Bristol-Myers Squibb Co. 1-indolyalkyl-4-(alkoxypyrimidinyl)piperazines
CA2043709C (fr) * 1990-06-29 2002-01-22 David W. Smith Derives pour combattre la migraine d'alcoxypirimidine

Also Published As

Publication number Publication date
RU2114111C1 (ru) 1998-06-27
AU661527B2 (en) 1995-07-27
CZ359292A3 (en) 1994-01-19
US5434154A (en) 1995-07-18
AU3003492A (en) 1994-03-24
FI925737A0 (fi) 1992-12-17
MX9207114A (es) 1993-07-01
JPH05262762A (ja) 1993-10-12
NO924764D0 (no) 1992-12-10
NZ245439A (en) 1995-07-26
PH30988A (en) 1997-12-23
FI925737L (fi) 1993-06-20
CN1085556A (zh) 1994-04-20
CA2084531A1 (fr) 1993-06-20
FI925737A7 (fi) 1993-06-20
EP0548813A1 (fr) 1993-06-30
NO924764L (no) 1993-06-21
IL104024A (en) 1997-04-15
TW221420B (fr) 1994-03-01

Similar Documents

Publication Publication Date Title
NO302522B1 (no) 4-pyrimidinyl- og pyridinylderivater av indolyl-3-yl-alkylpiperazin og farmasöytisk preparat som inneholder en slik forbindelse
US5300506A (en) Indolylalkyl derivatives of pyrimidinylpiperazine for treating vascular headache
RU2095360C1 (ru) Производные индола, их оптические изомеры и фармацевтически приемлемые соли
FI95698B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-indolyylialkyyli-4-(substituoitu pyridinyyli)piperatsiinien valmistamiseksi
EP0827746B1 (fr) Analogues de carbazole étant agonistes beta3-adrénergiques sélectifs
US5468768A (en) Antimigraine derivatives of indolylcycloalkanylamines
CA2059708C (fr) Derives d'indole
US5693655A (en) 3-indolylpiperidines
JP6434528B2 (ja) 置換ピリドン及びピラジノン、並びに好中球エラスターゼ活性の阻害剤としてのその使用
RU2136678C1 (ru) Производные n-замещенного 3-азабицикло[3.2.0]гептана
JP2010006813A (ja) うつ病および／又は不安症を治療するためのｇａｌ３受容体アンタゴニストの使用、およびこのような方法において有用な化合物
DE102004047272A1 (de) Inhibitoren der löslichen Adenylatzyklase
NO312243B1 (no) N-substituerte 3-azabicyklo[3.2.0]heptanderivater egnet som neuroleptika
US5618816A (en) Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and pyrimidinylpiperazines
HUP0300863A2 (hu) N-(3,5-diklór-2-metoxi-fenil)-4-metoxi-3-(1-piperazinil)-benzolszulfonamid, eljárás elżállítására és a vegyületet tartalmazó gyógyszerkészítmény
RU2478631C2 (ru) Соединения ((фенил)имидазолил)метилгетероарила, их применение, фармацевтическая композиция, содержащая указанные соединения, и набор, включающий такую композицию
AU673098B2 (en) Antimigraine cyclobutenedione derivatives of indolylalkyl-pyridinyl and pyrimidinylpiperazines
KR20000029564A (ko) 5ＨＴ2ｃ길항제및Ｄ2길항제를함유하는약제학적조성물
KR20100080541A (ko) Ｇ 단백질 억제제로서 사용되는 피라졸로-피라진 유도체
TWI322148B (en) Benzo [g] guinoline derivatives
WO2025139868A1 (fr) Inhibiteur de trpv3, sa préparation et son utilisation
NO772211L (no) Fremgangsm}te til fremstilling av nye 1-(azacykliske aralkoksyfenyl)-2- eller -3-(bis-arylalkylamino)-alkaner
JPS62226977A (ja) ピリジン誘導体
JPH10506095A (ja) 平滑筋弛緩薬としての（３，４−ジオキソシクロブテン−１−イル）クロメン、インデンおよびジヒドロナフタレノン誘導体
CA2327513A1 (fr) N-aryloxyethyle-indoly-alkylamines pour le traitement de la depression